Drug Profile
Ethinylestradiol/levonogestrel - Arstat
Alternative Names: NuvoceptLatest Information Update: 05 Oct 2023
Price :
$50
*
At a glance
- Originator ARSTAT
- Class Alkylated estrogenic steroids; Contraceptives; Norpregnanes; Norpregnatrienes; Progesterone congeners; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase Unknown Pregnancy
Most Recent Events
- 03 Oct 2023 Arstat Pharmaceuticals plans a phase III trial for Pregnancy (Prevention) (Arstat Pharmaceuticals pipeline, October 2023)
- 20 Jul 2016 Ethinylestradiol/levonogestrel - Arstat is available for licensing - http://arstatinc.com/ARSTAT_Contraceptive.pdf
- 20 Jul 2016 Investigation in Pregnancy (Prevention) in USA (PO)